Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition

Autor: K. de Joode, A. A. M. Oostvogels, C. H. GeurtsvanKessel, R. D. de Vries, R. H. J. Mathijssen, R. Debets, A. A. M. van der Veldt

Publikováno v: Frontiers in Immunology, Vol 12 (2021)

After the COVID-19 outbreak, non-evidence based guidelines were published to advise clinicians on the adjustment of oncological treatment during this pandemic. As immune checkpoint inhibitors directly affect the immune system, concerns have arisen ab

Externí odkaz: https://doaj.org/article/92b61b7902ce4c7f85ebcd544b1a1c52

Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients

Autor: Fleur van der Sijde, Willem A. Dik, Dana A. M. Mustafa, Eveline E. Vietsch, Marc G. Besselink, Reno Debets, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Marjolein Y. V. Homs, Quisette P. Janssen, Saskia A. C. Luelmo, Leonie J. M. Mekenkamp, Astrid A. M. Oostvogels, Marja A. W. Smits-te Nijenhuis, Johanna W. Wilmink, Casper H. J. van Eijck, the Dutch Pancreatic Cancer Group

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

BackgroundBiomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this study was to evaluate the association of circulating cytokines with FOLFIRINOX r

Externí odkaz: https://doaj.org/article/55155bc8478d42a488e7996f4f409527

Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania

Autor: Susana Santos, Iris Eekhout, Ellis Voerman, Romy Gaillard, Henrique Barros, Marie-Aline Charles, Leda Chatzi, Cécile Chevrier, George P. Chrousos, Eva Corpeleijn, Nathalie Costet, Sarah Crozier, Myriam Doyon, Merete Eggesbø, Maria Pia Fantini, Sara Farchi, Francesco Forastiere, Luigi Gagliardi, Vagelis Georgiu, Keith M. Godfrey, Davide Gori, Veit Grote, Wojciech Hanke, Irva Hertz-Picciotto, Barbara Heude, Marie-France Hivert, Daniel Hryhorczuk, Rae-Chi Huang, Hazel Inskip, Todd A. Jusko, Anne M. Karvonen, Berthold Koletzko, Leanne K. Küpers, Hanna Lagström, Debbie A. Lawlor, Irina Lehmann, Maria-Jose Lopez-Espinosa, Per Magnus, Renata Majewska, Johanna Mäkelä, Yannis Manios, Sheila W. McDonald, Monique Mommers, Camilla S. Morgen, George Moschonis, Ľubica Murínová, John Newnham, Ellen A. Nohr, Anne-Marie Nybo Andersen, Emily Oken, Adriëtte J. J. M. Oostvogels, Agnieszka Pac, Eleni Papadopoulou, Juha Pekkanen, Costanza Pizzi, Kinga Polanska, Daniela Porta, Lorenzo Richiardi, Sheryl L. Rifas-Shiman, Nel Roeleveld, Loreto Santa-Marina, Ana C. Santos, Henriette A. Smit, Thorkild I. A. Sørensen, Marie Standl, Maggie Stanislawski, Camilla Stoltenberg, Elisabeth Thiering, Carel Thijs, Maties Torrent, Suzanne C. Tough, Tomas Trnovec, Marleen M. H. J. van Gelder, Lenie van Rossem, Andrea von Berg, Martine Vrijheid, Tanja G. M. Vrijkotte, Oleksandr Zvinchuk, Stef van Buuren, Vincent W. V. Jaddoe

Publikováno v: BMC Medicine, Vol 16, Iss 1, Pp 1-15 (2018)

Abstract Background Gestational weight gain differs according to pre-pregnancy body mass index and is related to the risks of adverse maternal and child health outcomes. Gestational weight gain charts for women in different pre-pregnancy body mass in

Externí odkaz: https://doaj.org/article/56d967f80bc14023986888e5f26f9048

Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy: The ABCD study.

Autor: Adriëtte J J M Oostvogels, Wim B Busschers, Eline J M Spierings, Tessa J Roseboom, Maaike G J Gademan, Tanja G M Vrijkotte

Publikováno v: PLoS ONE, Vol 12, Iss 5, p e0177554 (2017)

OBJECTIVE:Although pre-pregnancy weight status and early pregnancy lipid profile are known to influence blood pressure course during pregnancy, little is known about how these two factors interact. The association between pre-pregnancy weight status

Externí odkaz: https://doaj.org/article/69dbb0818ce8472fbdf131bcf81a33ea

Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8(+) T cells

Autor: Maureen J.B. Aarts, Rebecca Wijers, Ronald de Wit, J. Alberto Nakauma-González, Joost L. Boormans, Paul Hamberg, Maud Rijnders, Hayri E. Balcioglu, Debbie Robbrecht, Astrid A. M. Oostvogels, Geert J.L.H. van Leenders, Reno Debets, Martijn P. Lolkema, Hans M. Westgeest, Astrid A M van der Veldt, Jens Voortman

Publikováno v: Clinical Cancer Research, 28(1), 215-226. American Association for Cancer Research Inc.
Clinical cancer research : an official journal of the American Association for Cancer Research, 28(1), 215-226. American Association for Cancer Research Inc.
Rijnders, M, Balcioglu, H E, Robbrecht, D G J, Oostvogels, A A M, Wijers, R, Aarts, M J B, Hamberg, P, van Leenders, G J L H, Nakauma-González, J A, Voortman, J, Westgeest, H M, Boormans, J L, de Wit, R, Lolkema, M, van der Veldt, A A M & Debets, R 2022, ' Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8 þ T cells ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 28, no. 1, pp. 215-226 . https://doi.org/10.1158/1078-0432.CCR-20-3319

Purpose: PD-1 inhibition results in durable antitumor responses in a proportion of patients with metastatic urothelial cancer (mUC). The majority of patients, however, do not experience clinical benefit. In this study, we aimed to identify early chan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a69daee782aa69493dfa0e1418167adf
https://cris.maastrichtuniversity.nl/en/publications/a365787a-45ef-4f74-b655-cf079a0b2d64